A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates
Abstract Non-alcoholic steatohepatitis (NASH) is a progressive and severe liver disease, characterized by lipid accumulation, inflammation, and downstream fibrosis. Despite its increasing prevalence, there is no approved treatment yet available for patients. This has been at least partially due to t...
Saved in:
Main Authors: | Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, Eva Thoma |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f68ec732dd9c4e5cbe369ca6c1215b3e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins in Non-alcoholic Steatohepatitis
by: Jose D. Torres-Peña, et al.
Published: (2021) -
Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
by: Chengyuan Liang, et al.
Published: (2021) -
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
by: Philippe Garteiser, et al.
Published: (2021) -
Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
by: Justine Gillard, et al.
Published: (2022) -
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice
by: Joost Willebrords, et al.
Published: (2017)